What is the recommended treatment for a Group B strep (Streptococcus agalactiae) urinary tract infection (UTI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Group B Streptococcus Urinary Tract Infection

For Group B Streptococcus (GBS) urinary tract infections, penicillin is the first-line treatment, with amoxicillin as an effective alternative based on high-quality evidence from clinical guidelines. 1

First-Line Treatment Options

Penicillin-Based Regimens (Preferred)

  • Penicillin V: 500 mg orally four times daily for 10 days 1
  • Amoxicillin: 500 mg orally three times daily for 10 days 1
  • Ampicillin: 2 g IV initial dose, then 1 g IV every 4 hours (for severe infections) 1

For Penicillin-Allergic Patients

  • Clindamycin: 300 mg orally four times daily for 10 days 1
    • Note: Recent studies show increasing clindamycin resistance (up to 77.34%) 2
  • Cefazolin: 2 g IV initial dose, then 1 g IV every 8 hours (for patients with non-anaphylactic penicillin allergy) 1

Treatment Algorithm Based on Infection Severity

Non-Severe UTI (Uncomplicated)

  1. First choice: Penicillin V or amoxicillin for 10 days
  2. Penicillin allergy: Clindamycin (if susceptible) for 10 days
  3. Alternative options:
    • Amoxicillin-clavulanic acid
    • Nitrofurantoin
    • Sulfamethoxazole-trimethoprim (if susceptible) 1

Severe UTI/Pyelonephritis

  1. First choice: IV ampicillin or penicillin G
  2. Penicillin allergy: IV clindamycin (if susceptible) or vancomycin
  3. Step-down therapy: Once clinical improvement occurs, transition to oral therapy to complete 10-14 days total 1

Special Considerations

Antibiotic Resistance Patterns

  • Recent studies show 100% sensitivity to penicillin, ampicillin, and vancomycin for GBS 2
  • High resistance rates to:
    • Clindamycin (77.34%)
    • Tetracycline (88.46%) 2
  • Always consider local resistance patterns when selecting antibiotics

Follow-up Recommendations

  • Clearance cultures should be taken 24 hours after completing treatment
  • Additional follow-up cultures at 1,3,6, and 12 weeks are recommended to ensure complete eradication 1

Treatment Failure

If initial treatment fails:

  1. Switch to clindamycin if penicillin was used initially (if susceptible)
  2. Consider combination therapy such as penicillin plus rifampicin 1, 3
  3. Investigate for anatomical abnormalities or other complicating factors
  4. Check for potential reservoirs of infection (vagina, urethra, gastrointestinal tract) 3

Pregnant Women with GBS UTI

  • All pregnant women with GBS bacteriuria at any point during pregnancy require intrapartum antibiotic prophylaxis (IAP) during labor 1, 4
  • GBS bacteriuria in pregnancy (regardless of colony count) is an indication for IAP 4
  • No need for repeat screening in the third trimester if GBS bacteriuria was previously documented 4

Pitfalls and Caveats

  • Failure to recognize GBS as a significant UTI pathogen, especially in women of childbearing age
  • Not considering local resistance patterns when selecting antibiotics
  • Inadequate follow-up to ensure complete eradication
  • Overlooking potential reservoirs of infection that may lead to recurrence
  • Failing to provide IAP during labor for pregnant women with history of GBS bacteriuria

GBS UTIs should be treated promptly with appropriate antibiotics to prevent complications and recurrence, with penicillin-based regimens remaining the most effective treatment option based on current evidence.

References

Guideline

Treatment of Genitourinary Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Management of group B streptococcal bacteriuria in pregnancy.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.